Page last updated: 2024-11-06

9-oxononanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9-oxononanoic acid, also known as pelargonic acid, is a nine-carbon fatty acid with a ketone functional group at the 9-position. It is a colorless liquid with a pungent odor, and it is found in nature in some plants and animals. 9-oxononanoic acid is a potent inducer of the peroxisome proliferator-activated receptor alpha (PPARĪ±), a nuclear receptor that plays an important role in lipid metabolism. Activation of PPARĪ± by 9-oxononanoic acid leads to increased expression of genes involved in fatty acid oxidation, reducing serum triglycerides and cholesterol levels. It has been studied as a potential therapeutic agent for the treatment of dyslipidemia, hyperlipidemia, and cardiovascular diseases. However, further research is needed to fully understand its safety and efficacy in humans. The compound has also been studied for its potential to stimulate the production of insulin, suggesting potential applications in the treatment of diabetes.'

9-oxononanoic acid: effects lipogenesis in rat liver [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

9-oxononanoic acid : A medium-chain oxo-fatty acid that is the 9-oxo derivative of nonanoic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75704
CHEBI ID78700
SCHEMBL ID1603841
MeSH IDM0154901

Synonyms (28)

Synonym
9-ketononanoic acid
2553-17-5
9-oxononanoic acid
9-oxo-nonanoic acid
LMFA01060160
AKOS006239261
nonanoic acid, 9-oxo-
unii-yh3q8rsx3z
yh3q8rsx3z ,
SCHEMBL1603841
8-formyloctanoic acid
CHEBI:78700
WLGDDELKYAWBBL-UHFFFAOYSA-N
AC-33586
DTXSID30180228
Q27147919
mfcd05864080
BS-16263
nonanal-9-oic acid
.omega.-oxononanoic acid
azelaaldehydic acid
fa 9:1+1o
C74321
SY253223
9-oxononanoicacid
EN300-220107
CAA55317
PD131330
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitorAn EC 6.4.1.* (C-C bond-forming ligase) inhibitor that interferes with the action of acetyl-CoA carboxylase (EC 6.4.1.2).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
aldehydic acidA monocarboxylic acid derived from any dicarboxylic acid that has a retained name by the formal reduction of one of the carboxy groups to a formyl group. The resulting structure, also known as a semialdehyde, may be named by replacing the ending '...ic acid' of the retained name of the dicarboxylic acid by the ending '...aldehydic acid'. Aldehydic acids therefore contain one carboxy group and one aldehyde group.
omega-oxo fatty acidAny oxo fatty acid in which the oxo group is located at the omega-position.
medium-chain fatty acidAny fatty acid with a chain length of between C6 and C12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.22 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]